Andrew Davies, MRCP, PhD from University of Southampton, Southampton, UK stresses the importance of educating patients about adverse effects of therapy for chronic lymphocytic leukemia (CLL) and follicular lymphoma. For example diarrhea and colitis can occur long after treatment with idelalisib according to Dr Davies. Recorded at the European Hematology Association (EHA) 2016 Annual Congress in Copenhagen, Denmark.